Dramatic Response to Carboplatin plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis

Research output: Contribution to journalArticlepeer-review

Abstract

Mucinous cystic neoplasm (MCN) of the pancreas is a rare cystic tumor occurring in the pancreatic body and tail in young to middle-aged women that is pathologically characterized by an ovarian-like stroma. Chemotherapy for recurrent/advanced pancreatic MCN has been based on chemotherapy regimens for pancreatic ductal adenocarcinoma, but the prognosis is poor. We herein report a 37-year-old woman with pancreatic mucinous cystadenocarcinoma with liver metastasis that responded dramatically to carboplatin plus paclitaxel therapy (CBDCA+PTX). CBDCA+PTX may be a treatment option for recurrent/advanced pancreatic MCN with an ovarian-like stroma.

Original languageEnglish
Pages (from-to)2967-2971
Number of pages5
JournalInternal Medicine
Volume60
Issue number18
DOIs
Publication statusPublished - 2021

Keywords

  • Carboplatin
  • Mucinous cystadenocarcinoma
  • Paclitaxel
  • Pancreas

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Dramatic Response to Carboplatin plus Paclitaxel in Pancreatic Mucinous Cystadenocarcinoma with Liver Metastasis'. Together they form a unique fingerprint.

Cite this